Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Prognostic value of circulating tumor DNA in operable non-small cell lung cancer: a systematic review and reconstructed individual patient-data based meta-analysis

Fig. 3

Synthesis of survival outcomes by longitudinal ctDNA status. A Individual patient data (IPD)-based disease-free survival (DFS) by longitudinal ctDNA status (+ vs. −). B IPD-based DFS by longitudinal ctDNA status (+ vs. −) based on propensity score matching (PSM). C IPD-based overall survival (OS) by longitudinal ctDNA status (+ vs. −). D pooled meta-analysis of DFS by longitudinal ctDNA status (+ vs. −)

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us